Cholesterol in Autism Spectrum Disorder (ASD): Characterization and Treatment

Initially designed as a randomized, double-blind, placebo-controlled clinical trial for children with autism spectrum disorder (ASD), enrollment ceased early due to lack of funding for extramural collaborators. One of the primary aims of the study was to establish the prevalence of hypocholesterolemia and hypercholesterolemia in idiopathic ASD. Available in DASH are laboratory results collected at multiple time points, including cholesterol levels, on 42 children enrolled during the first three years of the study